
Sign up to save your podcasts
Or


Key points:
This episode provides crucial insights into the evolving landscape of EU Health Technology Assessment (HTA) and the significant challenges ahead.
Stefan Walzer’s expertise sheds light on the pressures on pricing, clinical requirements, and the upcoming European Joint Clinical Assessment (JCA).
If you’re involved in the healthcare industry or have a keen interest in market access and health economics, this episode is a must-listen. Don’t keep these valuable insights to yourself—share this episode with your friends and colleagues who can benefit from understanding these pivotal developments.
Tune in now and join the conversation on shaping the future of healthcare in Europe.
By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry4.4
99 ratings
Key points:
This episode provides crucial insights into the evolving landscape of EU Health Technology Assessment (HTA) and the significant challenges ahead.
Stefan Walzer’s expertise sheds light on the pressures on pricing, clinical requirements, and the upcoming European Joint Clinical Assessment (JCA).
If you’re involved in the healthcare industry or have a keen interest in market access and health economics, this episode is a must-listen. Don’t keep these valuable insights to yourself—share this episode with your friends and colleagues who can benefit from understanding these pivotal developments.
Tune in now and join the conversation on shaping the future of healthcare in Europe.

78,459 Listeners

32,006 Listeners

30,695 Listeners

43,598 Listeners

9,556 Listeners

498 Listeners

168 Listeners

349 Listeners

8,579 Listeners

6,093 Listeners

29,248 Listeners

18 Listeners

3,045 Listeners

18 Listeners

21 Listeners